June 16 (Reuters) – Mabion SA: * SIGNS AGREEMENT WITH ODDIFACT SAS FOR FIRST STAGE OF COOPERATION ON PREPARING MABIONCD20 FOR FDA CONSULTATION * POTENTIAL ANNUAL MARKET VALUE OF CD20 TREATMENT IN U.S.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)